Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Rradem1flox/Cya
Common Name:
Rrad-flox
Product ID:
S-CKO-12098
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Rrad-flox
Strain ID
CKOCMP-56437-Rrad-B6J-VA
Gene Name
Rrad
Product ID
S-CKO-12098
Gene Alias
REM3; Rad
Background
C57BL/6JCya
NCBI ID
56437
Modification
Conditional knockout
Chromosome
8
Phenotype
MGI:1930943
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Rradem1flox/Cya mice (Catalog S-CKO-12098) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000034351
NCBI RefSeq
NM_019662
Target Region
Exon 3~5
Size of Effective Region
~1.8 kb
Detailed Document
Click here to download >>
Overview of Gene Research
RRAD, short for Ras-related associated with diabetes, is a member of the Ras-related GTPase superfamily. Primarily a cytosolic protein that activates in the plasma membrane, it is highly expressed in type 2 diabetes patients and serves as a biomarker for congestive heart failure. RRAD is involved in multiple cellular activities such as cell division, motility, apoptosis, and energy metabolism, by modulating tumor-related gene expression and interacting with downstream effectors [1].

In cancer, RRAD shows dual roles. In gastric and colorectal cancer, its inhibition via siRNA/shRNA led to decreased tumor cell proliferation in vitro and in vivo, along with reduced cell invasion, decreased EMT markers, angiogenesis, and associated proteins like VEGF and ANGP2, suggesting it could be a therapeutic target [2]. In papillary thyroid cancer, the NEAT1_2/RRAD/EHF positive feedback loop facilitated aerobic glycolysis [3]. In hepatocellular carcinoma, RRAD suppressed the Warburg effect by downregulating ACTG1, reducing cell proliferation, arresting the cell cycle, and increasing apoptosis [4]. In lung cancer, it inhibited the Warburg effect through negative regulation of the NF-κB signaling [5]. In contrast, in malignant glioblastoma, RRAD promoted EGFR-mediated STAT3 activation and temozolomide resistance [6]. In pancreatic cancer, SETD8 inhibited ferroptosis by inhibiting RRAD expression [7]. In oral squamous cell carcinoma, downregulation of RRAD in the tumor margin enhanced energy metabolism and tumor progression [8]. Also, RRAD was identified as a marker and negative regulator of cellular senescence, with its up-regulation countering cellular senescence by reducing reactive oxygen species levels [9].

In conclusion, RRAD is a multifunctional gene involved in various biological processes and diseases, especially cancer. Its dual role as either an oncogene or tumor suppressor depending on the cancer type highlights its complexity. Studies on RRAD using gene-knockout or conditional-knockout models (although not specifically detailed in the given references) could potentially further clarify its role in these biological processes and disease conditions, providing insights for targeted therapies.

References:
1. Sun, Zhangyue, Li, Yongkang, Tan, Xiaolu, Xu, Liyan, Long, Lin. 2023. Friend or Foe: Regulation, Downstream Effectors of RRAD in Cancer. In Biomolecules, 13, . doi:10.3390/biom13030477. https://pubmed.ncbi.nlm.nih.gov/36979412/
2. Kim, Hee Kyung, Lee, Inkyoung, Kim, Seung Tae, Park, Joon Oh, Kang, Won Ki. 2019. RRAD expression in gastric and colorectal cancer with peritoneal carcinomatosis. In Scientific reports, 9, 19439. doi:10.1038/s41598-019-55767-7. https://pubmed.ncbi.nlm.nih.gov/31857616/
3. Sun, Wei, Wang, Zhiyuan, Qin, Yuan, He, Liang, Zhang, Hao. . NEAT1_2/RRAD/EHF Positive Feedback Loop Facilitates Aerobic Glycolysis in Papillary Thyroid Cancer Cells. In Endocrinology, 164, . doi:10.1210/endocr/bqad085. https://pubmed.ncbi.nlm.nih.gov/37279586/
4. Yan, Yingcai, Xu, Hao, Zhang, Linshi, Ge, Wenhao, Wang, Weilin. 2019. RRAD suppresses the Warburg effect by downregulating ACTG1 in hepatocellular carcinoma. In OncoTargets and therapy, 12, 1691-1703. doi:10.2147/OTT.S197844. https://pubmed.ncbi.nlm.nih.gov/30881024/
5. Liu, Juan, Zhang, Cen, Wu, Rui, Yang, Bo, Feng, Zhaohui. . RRAD inhibits the Warburg effect through negative regulation of the NF-κB signaling. In Oncotarget, 6, 14982-92. doi:. https://pubmed.ncbi.nlm.nih.gov/25893381/
6. Yeom, Seon-Yong, Nam, Do-Hyun, Park, Chaehwa. 2014. RRAD promotes EGFR-mediated STAT3 activation and induces temozolomide resistance of malignant glioblastoma. In Molecular cancer therapeutics, 13, 3049-61. doi:10.1158/1535-7163.MCT-14-0244. https://pubmed.ncbi.nlm.nih.gov/25313011/
7. Lu, Zekun, Hu, Qiangsheng, Qin, Yi, Xu, Xiaowu, Chen, Xuemin. 2023. SETD8 inhibits ferroptosis in pancreatic cancer by inhibiting the expression of RRAD. In Cancer cell international, 23, 50. doi:10.1186/s12935-023-02899-6. https://pubmed.ncbi.nlm.nih.gov/36934248/
8. Cheng, Aoming, Xu, Qiaoshi, Li, Bo, Han, Zhengxue, Feng, Zhien. 2024. The enhanced energy metabolism in the tumor margin mediated by RRAD promotes the progression of oral squamous cell carcinoma. In Cell death & disease, 15, 376. doi:10.1038/s41419-024-06759-7. https://pubmed.ncbi.nlm.nih.gov/38811531/
9. Wei, Zhao, Guo, Haiyang, Qin, Junchao, Gong, Yaoqin, Shao, Changshun. 2018. Pan-senescence transcriptome analysis identified RRAD as a marker and negative regulator of cellular senescence. In Free radical biology & medicine, 130, 267-277. doi:10.1016/j.freeradbiomed.2018.10.457. https://pubmed.ncbi.nlm.nih.gov/30391675/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest